NR7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nomura Research Institute Ltd

Watchlist Manager

Watchlist

Price: 28.2 EUR -1.4% Market Closed

Market Cap: €16.2B

	Nomura Research Institute Ltd F:NR7	JP
D	DXP Enterprises Inc F:DX7	US
R	Ramsay Health Care Ltd F:RMY0	AU
S	Sumitomo Realty & Development Co Ltd F:RL2	JP
P	Procter & Gamble Co DUS:PRG	US
	Toho Co Ltd (Tokyo) F:TOH	JP
	Northam Platinum Holdings Ltd OTC:NPTLF	ZA
	Northeast Community Bancorp Inc F:JY4	US
L	Lonza Group AG XMUN:LO3	CH
	CTI Engineering Co Ltd TSE:9621	JP
	Immunome Inc NASDAQ:IMNM	US

Profitability Summary

Nomura Research Institute Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Sustainable 3Y Average Gross Margin

36%

Gross Margin is Increasing

35% > 37%

Low Operating Margin

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

16% > 7%

Low Net Margin

Sustainable 3Y Average Net Margin

10%

Declining Net Margin

11% > 2%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

10% > 14%

Low ROE

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

12% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.